RA Capital Management - ARCA BIOPHARMA INC ownership

ARCA BIOPHARMA INC's ticker is ABIOXXXX and the CUSIP is 00211Y407. A total of 17 filers reported holding ARCA BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RA Capital Management ownership history of ARCA BIOPHARMA INC
ValueSharesWeighting
Q4 2016$662,000
-55.1%
232,245
-55.5%
0.09%
-38.2%
Q3 2016$1,476,000
-9.6%
521,606
-7.3%
0.15%
-32.7%
Q2 2016$1,632,000
-39.6%
562,693
-27.7%
0.23%
-34.5%
Q1 2016$2,700,000
-25.4%
778,2110.0%0.34%
-3.6%
Q4 2015$3,619,000
-10.1%
778,211
-4.1%
0.36%
-38.1%
Q3 2015$4,024,000811,2270.58%
Other shareholders
ARCA BIOPHARMA INC shareholders Q4 2016
NameSharesValueWeighting ↓
Aveo Capital Partners, LLC 93,258$47,0000.02%
Tekla Capital Management LLC 811,227$405,0000.02%
Virtu Financial LLC 68,000$34,0000.00%
ROYCE & ASSOCIATES LP 326,147$163,0000.00%
BANK OF AMERICA CORP /DE/ 776$00.00%
NORTHERN TRUST CORP 14,074$7,0000.00%
MILLENNIUM MANAGEMENT LLC 11,124$6,0000.00%
DEUTSCHE BANK AG\ 352,030$175,0000.00%
CREDIT SUISSE AG/ 20,000$10,0000.00%
PANAGORA ASSET MANAGEMENT INC 88,994$44,0000.00%
View complete list of ARCA BIOPHARMA INC shareholders